ATOR-1015

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameATOR-1015

Drug Alias NameATOR-1015ADC-1015

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 modulatorsTumor necrosis factor receptor superfamily member 4 modulators

TargetsTumor necrosis factor receptor superfamily member 4Cytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenDenmark

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAlligator Bioscience Ab

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlligator Bioscience Ab

Active IndicationsN/A

Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A